European Committee on Antimicrobial Susceptibility Testing

Recommendations

Info

Gram-positive anaerobes except Clostridium difficile Fluoroquinolones MIC breakpoint (mg/L) EUCAST Clinical Breakpoint Tables v. 7.0, valid from 2017-01-01 Notes Numbered notes relate to general comments and/or MIC breakpoints. S ≤ R > Ciprofloxacin - - Levofloxacin - - Moxifloxacin IE IE Nalidixic acid (screen) NA NA Norfloxacin (uncomplicated UTI only) - - Ofloxacin - - Aminoglycosides MIC breakpoint (mg/L) Notes Numbered notes relate to general comments and/or MIC breakpoints. S ≤ R > Amikacin - - Gentamicin - - Netilmicin - - Tobramycin - - Glycopeptides and lipoglycopeptides MIC breakpoint (mg/L) Notes Numbered notes relate to general comments and/or MIC breakpoints. S ≤ R > Dalbavancin IE IE Oritavancin IE IE Teicoplanin IE IE Telavancin IE IE Vancomycin 2 2 65
Gram-positive anaerobes except Clostridium difficile Macrolides, lincosamides and streptogramins MIC breakpoint (mg/L) EUCAST Clinical Breakpoint Tables v. 7.0, valid from 2017-01-01 Notes Numbered notes relate to general comments and/or MIC breakpoints. S ≤ R > Azithromycin - - Clarithromycin - - Erythromycin IE IE Roxithromycin - - Telithromycin - - Clindamycin 4 4 Quinupristin-dalfopristin - - Tetracyclines 1 66 MIC breakpoint (mg/L) S ≤ R > Doxycycline Note 1 Note 1 Minocycline Note 1 Note 1 Tetracycline Note 1 Note 1 Tigecycline Note 1 Note 1 Notes Numbered notes relate to general comments and/or MIC breakpoints. 1. For anaerobic bacteria there is clinical evidence of activity in mixed intra-abdominal infections, but no correlation between MIC values, PK/PD data and clinical outcome. Therefore no breakpoints for susceptibility testing are given. Oxazolidinones MIC breakpoint (mg/L) Notes Numbered notes relate to general comments and/or MIC breakpoints. S ≤ R > Linezolid - - Tedizolid - -
Page 1 and 2:
European C
Page 3 and 4:
Guidance on reading EUCAST Breakpoi
Page 5 and 6:
Version 7.0, 2017-01-01 Acinetobact
Page 7 and 8:
Enterobacteriaceae EUCAST Clinical
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Pseudomonas spp. EUCAST Clinical Br
Page 15 and 16: Pseudomonas spp. EUCAST Clinical Br
Page 17 and 18: Acinetobacter spp. EUCAST Clinical
Page 19 and 20: Acinetobacter spp. EUCAST Clinical
Page 21 and 22: Staphylococcus spp. EUCAST Clinical
Page 27 and 28: Enterococcus spp. EUCAST Clinical B
Page 29 and 30: Enterococcus spp. EUCAST Clinical B
Page 31 and 32: Streptococcus groups A, B, C and G
Page 37 and 38: Streptococcus pneumoniae EUCAST Cli
Page 43 and 44: Viridans group streptococci EUCAST
Page 45 and 46: Viridans group streptococci EUCAST
Page 47 and 48: Haemophilus influenzae EUCAST Clini
Page 53 and 54: Moraxella catarrhalis EUCAST Clinic
Page 55 and 56: Moraxella catarrhalis EUCAST Clinic
Page 57 and 58: Neisseria gonorrhoeae EUCAST Clinic
Page 59 and 60: Neisseria gonorrhoeae EUCAST Clinic
Page 61 and 62: Neisseria meningitidis EUCAST Clini
Page 63 and 64: Neisseria meningitidis EUCAST Clini
Page 65: Gram-positive anaerobes except Clos
Page 69 and 70: Clostridium difficile EUCAST Clinic
Page 71 and 72: Gram-negative anaerobes EUCAST Clin
Page 73 and 74: Gram-negative anaerobes EUCAST Clin
Page 75 and 76: Listeria monocytogenes EUCAST Clini
Page 77 and 78: Pasteurella multocida EUCAST Clinic
Page 79 and 80: Corynebacterium spp. EUCAST Clinica
Page 81 and 82: Aerococcus sanguinicola and urinae
Page 83 and 84: Kingella kingae EUCAST Clinical Bre
Page 85 and 86: Mycobacterium tuberculosis EUCAST C
Page 87 and 88: PK/PD (Non-species related) breakpo
Page 89 and 90: PK/PD (Non-species related) breakpo
Page 91 and 92: Dosages EUCAST Clinical Breakpoint
Page 93 and 94: Dosages EUCAST Clinical Breakpoint
show all

European Committee on Antimicrobial Susceptibility Testing

Create successful ePaper yourself

Delete template?

Save as template?